Categories: Health

Ipsen – September 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights
and shares composing the share capital

(in accordance with Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)

Market: Euronext Paris
ISIN Code: FR 0010259150
LEI: 549300M6SGDPB4Z94P11

Date Total number of shares composing the share capital Total number of voting rights (1)
30 September 2025 83,814,526 Gross total* of voting rights: 132,053,087
Net total** of voting rights: 130,826,804

(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).

* Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings.

** Net total = total number of voting rights attached to the total number of shares – shares without voting rights.

GlobeNews Wire

Recent Posts

Singtel Receives Four Frost & Sullivan 2026 Recognitions for Leadership in Enterprise Connectivity, Cybersecurity, and Digital Transformation

The recognitions highlight Singtel's leadership in secure connectivity, network transformation, IoT innovation, and cybersecurity, delivering…

4 hours ago

4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population

July 18, 2026 15:15 ET  | Source: 4D Molecular Therapeutics, Inc. After a single intravitreal…

5 hours ago

Immuneering Corporation Announces Grants of Inducement Awards

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical…

5 hours ago

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

Silver Spring, MD, July 17, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration approved Lipfendra…

5 hours ago

Vitalist Announces Notice of Meeting & Record Date

CALGARY, Alberta, July 17, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. (TSX-V: VITA.V; OTCQB: VTLSF) ("Vitalist",…

10 hours ago

SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING AND BOARD CHANGES

July 17, 2026 17:00 ET  | Source: Spirit Blockchain Capital Inc. VANCOUVER, Canada, July 17,…

10 hours ago